India
Ophthalmology · 4 min read

Macular Degeneration

Learn about Macular Degeneration, its reported features, relevant specialists, and questions to discuss at a medical consultation.

Also known as: AMD; Age-Related Macular Degeneration

Compiled from public sources
Text selected and arranged from MedlinePlus (US National Library of Medicine) health topic. It describes the condition as those sources do; it has not been rewritten for India.
01 Oct 2026
Not medically reviewed
No registered doctor has reviewed this page. Use it to decide who to see and what to ask — not to diagnose or treat.
—
This is not medical advice. If symptoms are severe, sudden or getting worse, call 112 (or 108 for an ambulance) or go to the nearest emergency department.

The sources compiled here do not cover: diagnosis, prevention, prognosis, onset, prevalence. Ask the treating doctor about these.

Understanding the condition

From: MedlinePlus, National Library of Medicine

Macular degeneration, or age-related macular degeneration (AMD), is a leading cause of vision loss in Americans 60 and older. It is a disease that destroys your sharp, central vision. You need central vision to see objects clearly and to do tasks such as reading and driving.

AMD affects the macula, the part of the eye that allows you to see fine detail. It does not hurt, but it causes cells in the macula to die. There are two types: wet and dry. Wet AMD happens when abnormal blood vessels grow under the macula. These new blood vessels often leak blood and fluid. Wet AMD damages the macula quickly. Blurred vision is a common early symptom. Dry AMD happens when the light-sensitive cells in the macula slowly break down. You gradually lose your central vision. A common early symptom is that straight lines appear crooked.

Regular comprehensive eye exams can detect macular degeneration before the disease causes vision loss. Treatment can slow vision loss. It does not restore vision.

Understanding terms used in the source

These definitions explain medical words used above. A definition is not evidence that another condition is present, and it does not predict how a symptom will develop. Ask the clinician which terms apply to the actual examination or test result.

Macular degeneration
A nonspecific term denoting degeneration of the retinal pigment epithelium and/or retinal photoreceptor cells of the macula lutea.
Blurred vision
Lack of sharpness of vision resulting in the inability to see fine detail.
Central
Applies to an abnormality that is located close to the median plane or midline of the body or of the referenced structure.

Which doctor should you see?

The suggested department for discussing Macular Degeneration is Ophthalmology, with a ophthalmologist as the relevant type of clinician. Ophthalmologist; paediatric services for children as appropriate.

This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.

How to prepare for an assessment

Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.

Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.

  • Which part of the eye or visual pathway is affected?
  • What change in vision requires immediate contact with the eye service?
  • What are the aims and alternatives of any proposed eye treatment?

Treatment discussions and follow-up

Where the source describes treatments, these are an overview of possible care, not a prescription for an individual. Ask which option applies to the confirmed diagnosis, what benefit is expected, what adverse effects to watch for and how progress will be assessed. Availability, approvals and local practice can differ from the country described in the source.

Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.

The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.

When to seek emergency help

Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.

Questions about the diagnosis and everyday life

If Macular Degeneration is only suspected, ask what other explanations are being considered and what would distinguish them. Similar symptoms can occur in different conditions. A clinician should interpret the pattern of findings, the examination and any investigations together; reading a list of features cannot establish whether this diagnosis fits.

If the diagnosis is already confirmed, ask which features are relevant to you and which are only possible features described in a broader group. Check whether changes in daily activities are needed, whether another health problem affects the plan, and whether a written summary would help other clinicians understand your care.

When comparing care options, ask about the expected benefit, the likely time needed to assess improvement, the burdens of treatment, and reasonable alternatives. If costs, travel or availability make a plan difficult, raise this during the consultation so the team can discuss a workable follow-up arrangement. Do not assume that a specialist test or treatment described in an overseas source is routinely available locally.

Find a doctor for Macular Degeneration

This condition is usually assessed by an ophthalmologist. Every profile shows the doctor’s registration and what has been checked.

All ophthalmology conditions →

Sources

Source: MedlinePlus, National Library of Medicine. Orphadata Science: Free access data from Orphanet. © INSERM 1999; July 2026 data, CC BY 4.0. This product uses the Human Phenotype Ontology (hp/releases/2026-09-01). Only sources listed for this article apply. Source material has been selected and arranged; HPO definitions are reproduced without alteration. No source organisation endorses this compilation. Köhler S et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Research 2014;42(D1):D966–D974. doi:10.1093/nar/gkt1026.

General information, not advice about your situation. Errors can be reported through the corrections process. Reference TDI-C-1467.